Categories
Cancer Care (474)
I-CARE Early Covid (187)
I-CARE Flu and RSV (36)
I-PREVENT (153)
I-RECOVER Long Covid (111)
I-RECOVER Post-Vaccine (320)
MATH+ (288)
Tags
ACE2 protein (10)
acute respiratory distress syndrome (21)
Anti-inflammatory (13)
Antidepressants (9)
Ascorbic Acid (13)
autoantibodies (10)
autophagy (48)
Breast Cancer (30)
Cancer (69)
Cancer Stem Cells (11)
Chemotherapy (12)
Colon Cancer (11)
Corticosteroids (9)
COVID-19 (330)
COVID-19 Vaccines (8)
Curcumin (14)
Cytokines (13)
Depression (12)
Diabetes (14)
Famotidine (14)
Hydroxychloroquine (15)
Hyperbaric Oxygen Therapy (9)
Inflammation (15)
intermittent fasting (14)
ivermectin (53)
long COVID (21)
Macrophages (18)
Mast Cells (8)
Melatonin (23)
Mitochondria (14)
Myeloid Cells (10)
Pneumonia (9)
quercetin (15)
resveratrol (11)
SARS-CoV-2 (83)
Sepsis (22)
spermidine (11)
Spike Protein (12)
Thiamine (11)
Thrombosis (9)
Tinnitus (12)
Tumor (41)
Vitamin C (30)
Vitamin D (29)
Zinc (12)
Authors: Saha JK, Raihan J PMID: 33867777 PMCID: PMC8039806 DOI: 10.1007/s11224-021-01776-0 Abstract In this study, we have investigated the binding mechanism of two FDA-approved drugs (ivermectin and levosalbutamol) with the spike protein of SARs-CoV-2 using three different computational modeling techniques. Molecular docking results predict that ivermectin shows a large binding affinity for spike protein (− [...]
Categories: I-RECOVER Post-Vaccine
Tags: ivermectin, Levosalbutamol, SARS-CoV-2, Spike Protein
